SculptAdipotide
Targets fat cells directly.
About
What it is
Adipotide works differently from GLP-1s — it targets the blood supply to fat tissue, reducing fat stores by cutting off their nutrient delivery. A fundamentally different mechanism for body composition.
How it works
Adipotide contains a targeting sequence that binds to blood vessels feeding white adipose tissue, plus a cell-death sequence that disrupts those vessels. By cutting off blood supply to fat deposits, it causes fat cell apoptosis.
Benefits
Who it's for
What to expect
Week 1–2
Peptide begins targeting fat tissue vasculature.
Week 4–6
Fat tissue blood supply reduction progresses.
Week 8–12
Body composition changes become measurable.
Safety & tolerability
Adipotide works through a distinct mechanism from other weight management peptides. It requires careful monitoring of kidney function, as the peptide is cleared renally. Our care team conducts appropriate monitoring throughout your protocol.
How we compound
Single-source API
Every peptide is sourced from one vetted pharmaceutical-grade supplier — no blending from multiple sources.
Third-party tested
Independent labs verify purity, potency, sterility, and endotoxin levels before any batch is released.
Care team reviewed
A real person reviews your profile, your protocol, and your progress. Not an algorithm.
Weight Loss
SculptAdipotide
Every protocol is reviewed by our care team before it ships. Questions? Learn more
$179/mo
You might also consider
ContourSemaglutide
The GLP-1 that changed weight management forever.
EvolveTirzepatide
Dual-action GLP-1/GIP. The next generation of weight management.
Apex-3Retatrutide
Triple agonist. Three pathways. One injection.